We, Rafarma Pharmaceuticals, are a clinical-grade biopharmaceutical company that began in 2009 through the acquisition and subsequent consolidation of several pharmaceutical and biotechnology companies and scientific institutions that have been in continuous core business since 1930.

​

We manufacture sterile hospital drugs and devices and develop new products to implement the following core business areas:

✓Development and commercialization of innovative sterile biological, immunological and molecular targeted drugs to meet medical needs in cancer treatment, including medicine with radionuclides

✓ Development and implementation of devices and radiopharmaceuticals for nuclear medicine

✓We aim to be one of the fastest-growing companies in the pharmaceutical industry, combining cutting-edge development and traditional manufacturing methods in our approach